Ronald G. Gelbman

This profile gathers the share dealings of Ronald G. Gelbman across 2 companies, led by Haemonetics Corp and Serologicals Corp. In total, 73 filings cover trades dated from 13 March 2006 to 11 November 2019.

Both buying and selling appear: 4 purchases worth €156k, against 36 sales worth €6.5M. The net balance comes to €6.3M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 14 share grants and 18 option exercises. So far in 2019, the count stands at no purchases and 3 sales.

Half of the purchases are above €41k and half below. For 4 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 0% of cases, with a median move of -0.7%. Past outcomes like these are no guarantee of what comes next.

The record was last updated on 13 November 2019 with an option exercise (€333k) in Haemonetics Corp. The last purchase on record was published on 3 August 2006, which is 7,386 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.